Back to User profile » Dr Navid Hafez

Paper published by Dr Navid Hafez:


Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series

Yamamoto N, Tolcher A, Hafez N, Lugowska I, Ramlau R, Macarulla T, Geng J, Li J, Teufel M, Märten A, LoRusso P

OncoTargets and Therapy 2024, 17:267-280

Published Date: 29 March 2024